by Symmetron | Jan 19, 2019
Cancer Societal costs of Er+/Her2- advanced or metastatic breast cancer in post-menopausal women in the United Kingdom Value in Health. 2017; 20(9):A427 Authors Bermingham S, Schmid P, Forster F, Cornic L, Theti D, Smith A Noteworthy This is the first study to...
by Symmetron | Jan 17, 2019
Idiopathic Pulmonary Fibrosis  Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use PharmacoEconomics Open (2018) 1-10 Authors Diamantopoulos A, Maher TM, Esser D, LeReun C Process \ Retrospective analysis of resource use data...
Recent Comments